Stevanato Group S.p.A.
Stevanato Group S.p.A.'s revenue rose 7.5% to €1.2 billion in fiscal 2025. Its operating margin was 16.8%, up from 14.6% a year earlier. Free cash flow was €22 million. It paid out €15 million in dividends and buybacks, 66% of free cash flow. The diluted share count rose 0.7%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Income statement
From fiscal 2019 to 2025, earnings per share grew 21.3% a year and net income 23.6% a year, as new shares raised the share count by 14% and diluted each share's earnings.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 411 | 229 | 70 | 98 | 131 |
| Debt incl. finance leases | 220 | 198 | 378 | 412 | 455 |
| Net debt (negative means net cash) | −191 | −31 | 308 | 314 | 324 |
| Net debt to EBITDA | −0.9x | −0.1x | 1.1x | — | — |
| Debt to equity | 0.3x | 0.2x | 0.3x | 0.3x | 0.3x |
| Interest coverage | 37.9x | 57.2x | 53.8x | 26.4x | 35.4x |
| Current ratio | 2.6x | 1.8x | 1.5x | 1.8x | 1.8x |
| Quick ratio | 2.1x | 1.4x | 1.1x | 1.3x | 1.3x |
Cash flow
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 2 of 9 | 5 of 9 | 6 of 9 |
| Rule of 40 | −19.9% | −11.6% | 9.3% |
| Altman Z'' | 3.68 | 4.11 | 4.00 |
| Accruals ratio | 2.2% | −1.7% | −6.0% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Fail | Pass |
| Cash from operations exceeds net income | Fail | Pass | Pass |
| Debt fell relative to assets | Fail | Pass | Pass |
| Current ratio rose | Fail | Pass | Fail |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Fail | Fail | Pass |
| Revenue rose relative to assets | Fail | Fail | Fail |
| F-score | 2 of 9 | 5 of 9 | 6 of 9 |
Compare
Put Stevanato Group S.p.A. side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Stevanato Group S.p.A. | FY25 | 7.5% | 16.8% | 1.9% | 8.3% | — | 6 | |
| Embecta | FY25 | −3.8% | 22.4% | 16.9% | 29.3% | 4.3x | 6 | Compare |
| CONMED | FY25 | 5.2% | 7.5% | 11.0% | 3.7% | 5.1x | 6 | Compare |
| Tandem Diabetes Care | FY25 | 7.9% | −18.4% | −2.9% | −85.5% | — | 4 | Compare |
| LivaNova | FY25 | 10.7% | 14.4% | 12.5% | 12.8% | — | 5 | Compare |
7 years of figures
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 536 | 662 | 844 | 984 | 1,085 | 1,104 | 1,186 |
| Revenue growth | — | 23.4% | 27.5% | 16.6% | 10.3% | 1.7% | 7.5% |
| Gross profit | 138 | 194 | 265 | 320 | 340 | 302 | 344 |
| Research and development | 8 | 17 | 30 | 34 | 36 | 32 | 25 |
| Operating income | 62 | 103 | 162 | 192 | 201 | 161 | 199 |
| Net income | 39 | 78 | 134 | 143 | 146 | 118 | 140 |
| Diluted EPS (EUR) | 0.16 | 0.33 | 0.53 | 0.54 | 0.55 | 0.43 | 0.51 |
| Diluted shares (millions) | 240 | 240 | 253 | 265 | 265 | 271 | 273 |
| Cash flow | |||||||
| Cash from operations | 43 | 156 | 133 | 103 | 105 | 156 | 286 |
| Capital expenditure | 68 | 90 | 108 | 235 | 433 | 303 | 264 |
| Free cash flow | −26 | 66 | 26 | −132 | −328 | −147 | 22 |
| Dividends paid | 6 | 9 | 11 | 14 | 14 | 14 | 15 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | — | — | — | — | 1 | — | — |
| Balance sheet at fiscal year end | |||||||
| Cash and short-term investments | 85 | 116 | 411 | 229 | 70 | 98 | 131 |
| Debt incl. finance leases | — | 336 | 220 | 198 | 378 | 412 | 455 |
| Total assets | — | 968 | 1,419 | 1,660 | 2,072 | 2,329 | 2,544 |
| Total liabilities | — | 658 | 577 | 664 | 939 | 924 | 1,058 |
| Shareholders' equity | 265 | 310 | 842 | 996 | 1,132 | 1,404 | 1,486 |
| Margins and ratios | |||||||
| Gross margin | 25.7% | 29.3% | 31.4% | 32.5% | 31.3% | 27.4% | 29.0% |
| Operating margin | 11.6% | 15.6% | 19.2% | 19.6% | 18.5% | 14.6% | 16.8% |
| Net margin | 7.3% | 11.9% | 15.9% | 14.5% | 13.4% | 10.7% | 11.8% |
| Free cash flow margin | −4.8% | 10.0% | 3.0% | −13.4% | −30.2% | −13.3% | 1.9% |
| Rule of 40 (growth + FCF margin) | — | 33.4% | 30.5% | 3.2% | −19.9% | −11.6% | 9.3% |
| Return on capital | — | — | 22.2% | 18.2% | 12.8% | 7.5% | 8.3% |
| Return on equity | — | — | 23.3% | 15.5% | 13.7% | 9.3% | 9.7% |
| Return on assets | — | — | 11.3% | 9.3% | 7.8% | 5.3% | 5.7% |
| Net debt to EBITDA | — | 1.4x | −0.9x | −0.1x | 1.1x | — | — |